Similar articles for PMID: 15330953

Year	Number of Results
1975	1
1977	1
1982	1
1983	1
1984	2
1985	1
1986	2
1987	3
1988	3
1989	4
1990	5
1991	3
1992	2
1993	5
1994	2
1995	2
1996	4
1997	12
1998	3
1999	11
2000	20
2001	16
2002	18
2003	22
2004	32
2005	25
2006	8
2007	17
2008	11
2009	17
2010	23
2011	20
2012	22
2013	16
2014	27
2015	17
2016	13
2017	7
2018	13
2019	8
2020	5
2021	5
2022	5
2023	6
2024	0

1

Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.

Rapp HJ, Molnár V, Austin S, Krohn S, Gädeke V, Motsch J, Boos K, Williams DG, Gustafsson U, Huledal G, Larsson LE. Rapp HJ, et al. Paediatr Anaesth. 2004 Sep;14(9):724-32. doi: 10.1111/j.1460-9592.2004.01373.x. Paediatr Anaesth. 2004. PMID: 15330953 Clinical Trial.

2

Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants.

Bösenberg AT, Thomas J, Cronje L, Lopez T, Crean PM, Gustafsson U, Huledal G, Larsson LE. Bösenberg AT, et al. Paediatr Anaesth. 2005 Sep;15(9):739-49. doi: 10.1111/j.1460-9592.2004.01550.x. Paediatr Anaesth. 2005. PMID: 16101704

3

Stable plasma concentrations of unbound ropivacaine during postoperative epidural infusion for 24-72 hours in children.

Berde CB, Yaster M, Meretoja O, McCann ME, Huledal G, Gustafsson U, Larsson LE. Berde CB, et al. Eur J Anaesthesiol. 2008 May;25(5):410-7. doi: 10.1017/S0265021507003146. Epub 2008 Jan 21. Eur J Anaesthesiol. 2008. PMID: 18205962

4

Pharmacokinetic profiles of epidural bupivacaine and ropivacaine following single-shot and continuous epidural use in young infants.

Calder A, Bell GT, Andersson M, Thomson AH, Watson DG, Morton NS. Calder A, et al. Paediatr Anaesth. 2012 May;22(5):430-7. doi: 10.1111/j.1460-9592.2011.03771.x. Epub 2011 Dec 29. Paediatr Anaesth. 2012. PMID: 22211825

5

Serum ropivacaine concentrations and systemic local anesthetic toxicity in trauma patients receiving long-term continuous peripheral nerve block catheters.

Bleckner LL, Bina S, Kwon KH, McKnight G, Dragovich A, Buckenmaier CC 3rd. Bleckner LL, et al. Anesth Analg. 2010 Feb 1;110(2):630-4. doi: 10.1213/ANE.0b013e3181c76a33. Epub 2009 Dec 2. Anesth Analg. 2010. PMID: 19955504

6

Safety of 96-hour incision-site continuous infusion of ropivacaine for postoperative analgesia after bowel cancer resection.

Corso OH, Morris RG, Hewett PJ, Karatassas A. Corso OH, et al. Ther Drug Monit. 2007 Feb;29(1):57-63. doi: 10.1097/FTD.0b013e31802c59ec. Ther Drug Monit. 2007. PMID: 17304151 Clinical Trial.

7

Age and size are the major covariates for prediction of levobupivacaine clearance in children.

Chalkiadis GA, Anderson BJ. Chalkiadis GA, et al. Paediatr Anaesth. 2006 Mar;16(3):275-82. doi: 10.1111/j.1460-9592.2005.01778.x. Paediatr Anaesth. 2006. PMID: 16490091

8

In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally.

Van Obbergh LJ, Roelants FA, Veyckemans F, Verbeeck RK. Van Obbergh LJ, et al. Can J Anaesth. 2003 Jun-Jul;50(6):593-8. doi: 10.1007/BF03018647. Can J Anaesth. 2003. PMID: 12826553

9

Effect of perioperative administration of ropivacaine with epinephrine on postoperative pediatric adenotonsillectomy recovery.

Park AH, Pappas AL, Fluder E, Creech S, Lugo RA, Hotaling A. Park AH, et al. Arch Otolaryngol Head Neck Surg. 2004 Apr;130(4):459-64. doi: 10.1001/archotol.130.4.459. Arch Otolaryngol Head Neck Surg. 2004. PMID: 15096431 Clinical Trial.

10

Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.

Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E. Anderson BJ, et al. Paediatr Anaesth. 2005 Apr;15(4):282-92. doi: 10.1111/j.1460-9592.2005.01455.x. Paediatr Anaesth. 2005. PMID: 15787918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

409 results

Results by year